Metabolic Endocrinology Growth Hormone Deficiency

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Growth Hormone Deficiency Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Growth Hormone Deficiency Projects
--Altus Pharmaceuticals Inc
--AEterna Zentaris Inc
--Ardana plc
--Ambrx, Inc.
--Daewoong Pharmaceutical Co. Ltd.
--BioPartners GmbH
--Ipsen Ltd
--Emisphere Technologies Inc
--Mediolanum farmaceutici S.p.A.
--KAKEN PHARMACEUTICAL CO., LTD.
--Tercica Inc
--Novartis AG

--Top Companies in early stage Growth Hormone Deficiency Projects
--ConjuChem Inc.
--Alkermes Inc
--Eli Lilly & Co
--Dong-A Pharmaceutical Co., Ltd.
--HanAll Pharmaceutical
--Elixir Pharmaceuticals, Inc.
--Ipsen Ltd
--Hanmi Pharmaceutical Company Limited
--Modigene, Inc.
--Kowa Company, Ltd.
--OctoPlus N.V.
--Nautilus Biotech
--TransPharma Medical Ltd.
--Theratechnologies, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View